Developing nausea treatments for surgical and cancer patients.
Developing cost effective cytometers for laboratories. Acquired by Becton Dickinson.
Dermatologist-led biopharmaceutical company.
Gene therapy company.
Developing the next generation of cancer immunotherapies.
Cystoscopic technology for the treatment of overactive bladder.
Developing novel therapeutic compounds to treat disease.
Unlocking the power of benefits data.
Advancing therapies for the treatment of Idiopathic Pulmonary Fibrosis.
Short-term rental and hospitality startup.
Biotech company pioneering Antibody Oligonucleotide Conjugates.
Re-platforming global capital markets.
Life sciences R&D cloud platform.
AI-powered platform for drug discovery.
Developing novel therapies for diseases of the eye.
Developing products for vascular and general surgeons.
Developing personalised, highly-selective cancer therapies.
Symptom and cure checker that uses an intelligent algorithm to diagnose patients.
Developing lixivaptan, an oral compound for the potential treatment of hyponatremia.
Gene editing company.
Centivo is a new type of self-funded health plan built specifically for employers and their employees and families. The Company targets zero healthcare trend and improved healthcare outcomes by rewar
Developing approaches to activate the immune system to recognise and destroy tumour cells.
Distributed NoSQL database-as-a-service for developers.
Cloud-based platform helping software developers test and deploy their code.
Developing and commercialising high-quality biosimilar therapeutics.
Comprehensively drugging the tumor-immune synapse with human antibodies.
Tech-enabled health insurance and clinical services solution.
Develops AAV gene therapies for rare disease. Acquired by Ultragenyx Pharmaceuticals.
A canine genomics and biotechnology company.
Interest rate swaps trading venue.
FinTech company connecting people with personalised financial products.
Medical devices company.
Primary care provider.
Provider of high-ticket payment solutions.